2/6
05:33 pm
imux
Immunic (NASDAQ:IMUX) was upgraded by analysts at Brookline Cap M to a "strong-buy" rating.
Low
Report
Immunic (NASDAQ:IMUX) was upgraded by analysts at Brookline Cap M to a "strong-buy" rating.
2/5
06:10 am
imux
Immunic (NASDAQ:IMUX) was upgraded by analysts at Brookline Capital Management to a "strong-buy" rating.
Medium
Report
Immunic (NASDAQ:IMUX) was upgraded by analysts at Brookline Capital Management to a "strong-buy" rating.
2/4
07:22 am
imux
Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the ACTRIMS Forum 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis [Yahoo! Finance]
Medium
Report
Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the ACTRIMS Forum 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis [Yahoo! Finance]
2/4
06:30 am
imux
Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the ACTRIMS Forum 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis
Medium
Report
Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the ACTRIMS Forum 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis
1/12
04:40 am
imux
Immunic (IMUX) Reviews 2025 Performance and Highlights Upcoming Milestones, Shares Up 24.10% [Yahoo! Finance]
Medium
Report
Immunic (IMUX) Reviews 2025 Performance and Highlights Upcoming Milestones, Shares Up 24.10% [Yahoo! Finance]
1/7
09:24 am
imux
Immunic (NASDAQ:IMUX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $8.00 price target on the stock.
Medium
Report
Immunic (NASDAQ:IMUX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $8.00 price target on the stock.
1/7
07:22 am
imux
Immunic Highlights 2025 Accomplishments and Upcoming Milestones [Yahoo! Finance]
Medium
Report
Immunic Highlights 2025 Accomplishments and Upcoming Milestones [Yahoo! Finance]
1/7
06:30 am
imux
Immunic Highlights 2025 Accomplishments and Upcoming Milestones
Medium
Report
Immunic Highlights 2025 Accomplishments and Upcoming Milestones
12/16
04:37 pm
imux
Immunic (NASDAQ:IMUX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Immunic (NASDAQ:IMUX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/26
02:09 pm
imux
Immunic (NASDAQ:IMUX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Immunic (NASDAQ:IMUX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/26
07:10 am
imux
Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December [Yahoo! Finance]
Low
Report
Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December [Yahoo! Finance]
11/26
06:30 am
imux
Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December
Low
Report
Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December
11/21
05:31 am
imux
Immunic (NASDAQ:IMUX) was upgraded by analysts at Chardan Capital to a "strong-buy" rating.
Low
Report
Immunic (NASDAQ:IMUX) was upgraded by analysts at Chardan Capital to a "strong-buy" rating.
11/14
08:09 am
imux
Immunic (NASDAQ:IMUX) had its price target lowered by analysts at HC Wainwright from $10.00 to $8.00. They now have a "buy" rating on the stock.
Medium
Report
Immunic (NASDAQ:IMUX) had its price target lowered by analysts at HC Wainwright from $10.00 to $8.00. They now have a "buy" rating on the stock.
11/13
09:01 am
imux
Immunic (NASDAQ:IMUX) had its price target lowered by analysts at D. Boral Capital from $10.00 to $8.00. They now have a "buy" rating on the stock.
Medium
Report
Immunic (NASDAQ:IMUX) had its price target lowered by analysts at D. Boral Capital from $10.00 to $8.00. They now have a "buy" rating on the stock.
11/13
06:30 am
imux
Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Medium
Report
Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update